{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:11:06Z","timestamp":1778634666959,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very limited data are available on the total contribution of Gag residues to resistance to PIs. To identify in detail Gag residues and structural interfaces associated with the development of HIV-1 resistance to PIs, we traced viral evolution under the pressure of PIs using Gag-protease single genome sequencing and coevolution analysis of protein sequences in 4 patients treated with PIs over a 9-year period. We identified a total of 38 Gag residues correlated with the protease, 32 of which were outside Gag cleavage sites. These residues were distributed in 23 Gag-protease groups of coevolution, with the viral matrix and the capsid represented in 87% and 52% of the groups. In addition, we uncovered the distribution of Gag correlated residues in specific protein surfaces of the inner face of the viral matrix and at the Cyclophilin A binding loop of the capsid. In summary, our findings suggest a tight interdependency between Gag structural proteins and the protease during the development of resistance of HIV-1 to PIs.<\/jats:p>","DOI":"10.1038\/s41598-017-03260-4","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T11:31:10Z","timestamp":1497267070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors"],"prefix":"10.1038","volume":"7","author":[{"given":"Francisco M","family":"Codo\u00f1er","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Blanch-Lombarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Jimenez-Moyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vollbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Draenert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia G.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"key":"3260_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.2010.1004","volume":"304","author":"MA Thompson","year":"2010","unstructured":"Thompson, M. A. et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA \n                           304, 321\u2013333 (2010).","journal-title":"JAMA"},{"key":"3260_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/jac\/dkv205","volume":"70","author":"JR Santos","year":"2015","unstructured":"Santos, J. R. et al. Monotherapy with boosted PIs as an ART simplification strategy in clinical practice. J Antimicrob Chemother \n                           70, 1124\u20131129 (2015).","journal-title":"J Antimicrob Chemother"},{"key":"3260_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/jac\/dkn103","volume":"61","author":"F Pulido","year":"2008","unstructured":"Pulido, F. et al. Long-term (4 years) efficacy of lopinavir\/ritonavir monotherapy for maintenance of HIV suppression. J Antimicrob Chemother \n                           61, 1359\u20131361 (2008).","journal-title":"J Antimicrob Chemother"},{"key":"3260_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-4690-9-63","volume":"9","author":"A Fun","year":"2012","unstructured":"Fun, A., Wensing, A. M., Verheyen, J. & Nijhuis, M. Human Immunodeficiency Virus Gag and protease: partners in resistance. Retrovirology \n                           9, 63 (2012).","journal-title":"Retrovirology"},{"key":"3260_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-4690-9-29","volume":"9","author":"van Maarseveen","year":"2012","unstructured":"van Maarseveen et al. Modulation of HIV-1 Gag NC\/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity. Retrovirology \n                           9, 29 (2012).","journal-title":"Retrovirology"},{"key":"3260_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/00002030-200205030-00007","volume":"16","author":"JG Prado","year":"2002","unstructured":"Prado, J. G. et al. Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity. AIDS \n                           16, 1009\u20131017 (2002).","journal-title":"AIDS"},{"key":"3260_CR7","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1371\/journal.pmed.0040036","volume":"4","author":"M Nijhuis","year":"2007","unstructured":"Nijhuis, M. et al. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. PLoS Med \n                           4, e36 (2007).","journal-title":"PLoS Med"},{"key":"3260_CR8","doi-asserted-by":"publisher","first-page":"e0137834","DOI":"10.1371\/journal.pone.0137834","volume":"10","author":"KA Sutherland","year":"2015","unstructured":"Sutherland, K. A. et al. Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLoS One \n                           10, e0137834 (2015).","journal-title":"PLoS One"},{"key":"3260_CR9","doi-asserted-by":"publisher","first-page":"e1000345","DOI":"10.1371\/journal.ppat.1000345","volume":"5","author":"E Dam","year":"2009","unstructured":"Dam, E. et al. Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss. PLoS Pathog \n                           5, e1000345 (2009).","journal-title":"PLoS Pathog"},{"key":"3260_CR10","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1128\/JVI.02356-08","volume":"83","author":"CM Parry","year":"2009","unstructured":"Parry, C. M. et al. Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1. J Virol \n                           83, 9094\u20139101 (2009).","journal-title":"J Virol"},{"key":"3260_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1128\/AAC.01228-10","volume":"55","author":"CM Parry","year":"2011","unstructured":"Parry, C. M. et al. Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity. Antimicrob Agents Chemother \n                           55, 1106\u20131113 (2011).","journal-title":"Antimicrob Agents Chemother"},{"key":"3260_CR12","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1172\/JCI67399","volume":"123","author":"SA Rabi","year":"2013","unstructured":"Rabi, S. A. et al. Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance. J Clin Invest \n                           123, 3848\u20133860 (2013).","journal-title":"J Clin Invest"},{"key":"3260_CR13","doi-asserted-by":"publisher","first-page":"e1003198","DOI":"10.1371\/journal.ppat.1003198","volume":"9","author":"W Muranyi","year":"2013","unstructured":"Muranyi, W., Malkusch, S., M\u00fcller, B., Heilemann, M. & Kr\u00e4usslich, H. G. Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog \n                           9, e1003198 (2013).","journal-title":"PLoS Pathog"},{"key":"3260_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/QAD.0b013e32833160fa","volume":"24","author":"J Verheyen","year":"2010","unstructured":"Verheyen, J. et al. High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates. AIDS \n                           24, 669\u2013673 (2010).","journal-title":"AIDS"},{"key":"3260_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jinf.2006.06.012","volume":"54","author":"I Malet","year":"2007","unstructured":"Malet, I. et al. Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients. J Infect \n                           54, 367\u2013374 (2007).","journal-title":"J Infect"},{"key":"3260_CR16","doi-asserted-by":"publisher","first-page":"e1003461","DOI":"10.1371\/journal.ppat.1003461","volume":"9","author":"SJ Rihn","year":"2013","unstructured":"Rihn, S. J. et al. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog \n                           9, e1003461 (2013).","journal-title":"PLoS Pathog"},{"key":"3260_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1128\/JVI.01500-08","volume":"83","author":"DC Tully","year":"2009","unstructured":"Tully, D. C. & Fares, M. A. Shifts in the selection-drift balance drive the evolution and epidemiology of foot-and-mouth disease virus. J Virol \n                           83, 781\u2013790 (2009).","journal-title":"J Virol"},{"key":"3260_CR18","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/molbev\/msm213","volume":"24","author":"SA Travers","year":"2007","unstructured":"Travers, S. A., Tully, D. C., McCormack, G. P. & Fares, M. A. A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes. Mol Biol Evol \n                           24, 2787\u20132801 (2007).","journal-title":"Mol Biol Evol"},{"key":"3260_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/1471-2148-10-310","volume":"10","author":"FM Codo\u00f1er","year":"2010","unstructured":"Codo\u00f1er, F. M., Alfonso-Loeches, S. & Fares, M. A. Mutational dynamics of murine angiogenin duplicates. BMC Evol Biol \n                           10, 310 (2010).","journal-title":"BMC Evol Biol"},{"key":"3260_CR20","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.02660-07","volume":"82","author":"J Salazar-Gonzalez","year":"2008","unstructured":"Salazar-Gonzalez, J. et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol \n                           82, 3952\u20133970 (2008).","journal-title":"J Virol"},{"key":"3260_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","volume":"43","author":"S Palmer","year":"2005","unstructured":"Palmer, S. et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol \n                           43, 406\u2013413 (2005).","journal-title":"J Clin Microbiol"},{"key":"3260_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jviromet.2010.04.030","volume":"168","author":"MR Jordan","year":"2010","unstructured":"Jordan, M. R. et al. Comparison of standard PCR\/cloning to single genome sequencing for analysis of HIV-1 populations. J Virol Methods \n                           168, 114\u2013120 (2010).","journal-title":"J Virol Methods"},{"key":"3260_CR23","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1073\/pnas.93.7.3099","volume":"93","author":"CP Hill","year":"1996","unstructured":"Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M. & Sundquist, W. I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci USA \n                           93, 3099\u20133104 (1996).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3260_CR24","first-page":"537","volume":"9","author":"C Tang","year":"2002","unstructured":"Tang, C., Ndassa, Y. & Summers, M. F. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol \n                           9, 537\u2013543 (2002).","journal-title":"Nat Struct Biol"},{"key":"3260_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1074\/jbc.M505920200","volume":"281","author":"H Gatanaga","year":"2006","unstructured":"Gatanaga, H. et al. Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop. J Biol Chem \n                           281, 1241\u20131250 (2006).","journal-title":"J Biol Chem"},{"key":"3260_CR26","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1128\/AAC.02682-15","volume":"60","author":"J Giandhari","year":"2016","unstructured":"Giandhari, J. et al. Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy. Antimicrob Agents Chemother \n                           60, 2248\u20132256 (2016).","journal-title":"Antimicrob Agents Chemother"},{"key":"3260_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.it.2005.01.003","volume":"26","author":"M Lichterfeld","year":"2005","unstructured":"Lichterfeld, M., Yu, X. G., Le Gall, S. & Altfeld, M. Immunodominance of HIV-1-specific CD8(+) T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics. Trends Immunol \n                           26, 166\u2013171 (2005).","journal-title":"Trends Immunol"},{"key":"3260_CR28","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1128\/JVI.00865-13","volume":"87","author":"G Turk","year":"2013","unstructured":"Turk, G. et al. Early Gag immunodominance of the HIV-specific T-cell response during acute\/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment. J Virol \n                           87, 7445\u20137462 (2013).","journal-title":"J Virol"},{"key":"3260_CR29","doi-asserted-by":"publisher","first-page":"e1004249","DOI":"10.1371\/journal.pcbi.1004249","volume":"11","author":"WF Flynn","year":"2015","unstructured":"Flynn, W. F. et al. Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease. PLoS Comput Biol \n                           11, e1004249 (2015).","journal-title":"PLoS Comput Biol"},{"key":"3260_CR30","doi-asserted-by":"publisher","first-page":"e1003739","DOI":"10.1371\/journal.ppat.1003739","volume":"9","author":"PR Tedbury","year":"2013","unstructured":"Tedbury, P. R., Ablan, S. D. & Freed, E. O. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog \n                           9, e1003739 (2013).","journal-title":"PLoS Pathog"},{"key":"3260_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.tim.2014.04.012","volume":"22","author":"PR Tedbury","year":"2014","unstructured":"Tedbury, P. R. & Freed, E. O. The role of matrix in HIV-1 envelope glycoprotein incorporation. Trends Microbiol \n                           22, 372\u2013378 (2014).","journal-title":"Trends Microbiol"},{"key":"3260_CR32","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1128\/JVI.02122-06","volume":"81","author":"A Alfadhli","year":"2007","unstructured":"Alfadhli, A., Huseby, D., Kapit, E., Colman, D. & Barklis, E. Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J Virol \n                           81, 1472\u20131478 (2007).","journal-title":"J Virol"},{"key":"3260_CR33","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.1128\/JVI.01369-07","volume":"81","author":"MA Brockman","year":"2007","unstructured":"Brockman, M. A. et al. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol \n                           81, 12608\u201312618 (2007).","journal-title":"J Virol"},{"key":"3260_CR34","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1128\/JVI.80.7.3617-3623.2006","volume":"80","author":"J Martinez-Picado","year":"2006","unstructured":"Martinez-Picado, J. et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol \n                           80, 3617\u20133623 (2006).","journal-title":"J Virol"},{"key":"3260_CR35","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1074\/jbc.M108005200","volume":"277","author":"H Gatanaga","year":"2002","unstructured":"Gatanaga, H. et al. Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors. J Biol Chem \n                           277, 5952\u20135961 (2002).","journal-title":"J Biol Chem"},{"key":"3260_CR36","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/molbev\/msw206","volume":"33","author":"R Polster","year":"2016","unstructured":"Polster, R., Petropoulos, C. J., Bonhoeffer, S. & Guillaume, F. Epistasis and Pleiotropy Affect the Modularity of the Genotype-Phenotype Map of Cross-Resistance in HIV-1. Mol Biol Evol \n                           33, 3213\u20133225 (2016).","journal-title":"Mol Biol Evol"},{"key":"3260_CR37","doi-asserted-by":"publisher","first-page":"12456","DOI":"10.1073\/pnas.1615342113","volume":"113","author":"L Deshmukh","year":"2016","unstructured":"Deshmukh, L., Louis, J. M., Ghirlando, R. & Clore, G. M. Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations. Proc Natl Acad Sci USA \n                           113, 12456\u201312461 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"3260_CR38","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura, K. et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol \n                           28, 2731\u20132739 (2011).","journal-title":"Mol Biol Evol"},{"key":"3260_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1534\/genetics.105.053249","volume":"173","author":"MA Fares","year":"2006","unstructured":"Fares, M. A. & Travers, S. A. A novel method for detecting intramolecular coevolution: adding a further dimension to selective constraints analyses. Genetics \n                           173, 9\u201323 (2006).","journal-title":"Genetics"},{"key":"3260_CR40","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1093\/bioinformatics\/btl493","volume":"22","author":"MA Fares","year":"2006","unstructured":"Fares, M. A. & McNally, D. CAPS: coevolution analysis using protein sequences. Bioinformatics \n                           22, 2821\u20132822 (2006).","journal-title":"Bioinformatics"},{"key":"3260_CR41","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","volume":"89","author":"S Henikoff","year":"1992","unstructured":"Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA \n                           89, 10915\u201310919 (1992).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3260_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0022-1759(02)00541-0","volume":"275","author":"R Draenert","year":"2003","unstructured":"Draenert, R. et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods \n                           275, 19\u201329 (2003).","journal-title":"J Immunol Methods"},{"key":"3260_CR43","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","volume":"77","author":"MM Addo","year":"2003","unstructured":"Addo, M. M. et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol \n                           77, 2081\u20132092 (2003).","journal-title":"J Virol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03260-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03260-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03260-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:28:12Z","timestamp":1671773292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03260-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3260"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03260-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]},"assertion":[{"value":"10 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3717"}}